Unaudited Condensed Consolidated Balance Sheets (USD $) In Thousands, unless otherwise specified	Dec. 28, 2012		Mar. 30, 2012
Assets, Current [Abstract]
Cash and cash equivalents	$ 216,134		$ 163,152
Accounts receivable, net of allowance for doubtful accounts of $4,004 and $3,410 as of December 28, 2012 and March 30, 2012, respectively	204,186		189,542
Inventories	177,482		147,198
Prepaid expenses	6,354		4,936
Other current assets	53,120		39,250
Assets held for sale	252,420	[1]	277,378	[1]
Total current assets	909,696		821,456
Property and equipment, net of accumulated depreciation of $148,611 and $134,235 as of December 28, 2012 and March 30, 2012, respectively	82,420		80,151
Other Assets, Noncurrent [Abstract]
Goodwill	143,476		109,457
Intangibles, net of accumulated amortization of $19,008 and $14,037 as of December 28, 2012 and March 30, 2012, respectively	52,270		33,546
Other assets	118,954		111,360
Total assets	1,306,816	[1]	1,155,970	[1]
Liabilities, Current [Abstract]
Accounts payable	147,379		118,719
Accrued expenses	55,892		37,436
Current portion of long-term debt	212,387		0
Other current liabilities	39,842		8,015
Liabilities held for sale	40,516	[1]	37,640	[1]
Total current liabilities	496,016		201,810
Revolving line of credit and long-term debt, excluding current portion	250,000		454,916
Other noncurrent liabilities	109,431		108,433
Total liabilities	855,447	[1]	765,159
Commitments and contingencies (Note 13)
Equity [Abstract]
Preferred stock, $0.01 par value; 1,000,000 shares authorized, no shares issued and outstanding	0		0
Common stock, $0.01 par value; 150,000,000 shares authorized, 50,328,843 and 50,312,323 shares issued and outstanding as of December 28, 2012 and March 30, 2012, respectively	495		495
Retained earnings	447,779		386,633
Total PSS World Medical, Inc. shareholders' equity	448,274		387,128
Noncontrolling interest	3,095		3,683
Total equity	451,369		390,811
Total liabilities and equity	$ 1,306,816		$ 1,155,970

[1] See Footnote 3, Discontinued Operations and Plan of Merger, for discussion of assets and liabilities held for sale. See Footnote 4, Variable Interest Entity, for discussion of the assets and liabilities related to the Company’s consolidated variable interest entities.